{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:39:46Z","timestamp":1792661986639,"version":"4.5.0"},"reference-count":30,"publisher":"e-Century Publishing Corporation","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/qwcj1378","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T02:53:22Z","timestamp":1767754402000},"page":"9365-9376","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of combined Linggui Bafa Tui Na and Fuxiong San herbal powder therapy in pediatric Mycoplasma pneumonia"],"prefix":"10.62347","volume":"17","author":[{"given":"Yanjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","unstructured":"Lu Y, Wang Y, Hao C, Ji W, Chen Z, Jiang W, Yan Y and Gu W. Clinical characteristics of pneumonia caused by mycoplasma pneumoniae in children of different ages. Int J Clin Exp Pathol 2018; 11: 855-861."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1542\/pir.2018-0016","article-title":"Mycoplasma pneumonia in children and adolescents","volume":"41","author":"Krafft","year":"2020","unstructured":"Krafft C and Christy C. Mycoplasma pneumonia in children and adolescents. Pediatr Rev 2020; 41: 12-19.","journal-title":"Pediatr Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3345\/kjp.2018.07367","article-title":"Benefits and risks of therapeutic alternatives for macrolide resistant mycoplasma pneumoniae pneumonia in children","volume":"62","author":"Yang","year":"2019","unstructured":"Yang HJ. Benefits and risks of therapeutic alternatives for macrolide resistant mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 2019; 62: 199-205.","journal-title":"Korean J Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3345\/cep.2020.01305","article-title":"Consideration in treatment decisions for refractory mycoplasma pneumoniae pneumonia","volume":"64","author":"Cho","year":"2021","unstructured":"Cho HK. Consideration in treatment decisions for refractory mycoplasma pneumoniae pneumonia. Clin Exp Pediatr 2021; 64: 459-467.","journal-title":"Clin Exp Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"109900","DOI":"10.1016\/j.biopha.2020.109900","article-title":"Data mining and systematic pharmacology to reveal the mechanisms of traditional Chinese medicine in mycoplasma pneumoniae pneumonia treatment","volume":"125","author":"Sun","year":"2020","unstructured":"Sun JH, Sun F, Yan B, Li JY and Xin L. Data mining and systematic pharmacology to reveal the mechanisms of traditional Chinese medicine in mycoplasma pneumoniae pneumonia treatment. Biomed Pharmacother 2020; 125: 109900.","journal-title":"Biomed Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"678631","DOI":"10.3389\/fphar.2021.678631","article-title":"Chinese herbal medicine for the treatment of children and adolescents with refractory mycoplasma pneumoniae pneumonia: a systematic review and a meta-analysis","volume":"12","author":"Ling","year":"2021","unstructured":"Ling X, Sun X, Kong H, Peng S, Yu Z, Wen J and Yuan B. Chinese herbal medicine for the treatment of children and adolescents with refractory mycoplasma pneumoniae pneumonia: a systematic review and a meta-analysis. Front Pharmacol 2021; 12: 678631.","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"115308","DOI":"10.1016\/j.jep.2022.115308","article-title":"Exploring the mechanism of Qinbaiqingfei-concentrate pills in the treatment of mycoplasma pneumoniae pneumonia from the perspective of intestinal microbiota and mucosal immunity","volume":"293","author":"Liu","year":"2022","unstructured":"Liu Z, Dong WT, Wei WF, Huo JH and Wang WM. Exploring the mechanism of Qinbaiqingfei-concentrate pills in the treatment of mycoplasma pneumoniae pneumonia from the perspective of intestinal microbiota and mucosal immunity. J Ethnopharmacol 2022; 293: 115308.","journal-title":"J Ethnopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"761883","DOI":"10.3389\/fphar.2021.761883","article-title":"A study based on metabolomics, network pharmacology, and experimental verification to explore the mechanism of Qinbaiqingfei concentrated pills in the treatment of mycoplasma pneumonia","volume":"12","author":"Liu","year":"2021","unstructured":"Liu Z, Huo JH, Dong WT, Sun GD, Li FJ, Zhang YN, Qin ZW, Pengna J and Wang WM. A study based on metabolomics, network pharmacology, and experimental verification to explore the mechanism of Qinbaiqingfei concentrated pills in the treatment of mycoplasma pneumonia. Front Pharmacol 2021; 12: 761883.","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wang K, Gill P, Perera R, Thomson A, Mant D and Harnden A. Clinical symptoms and signs for the diagnosis of mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev 2012; 10: CD009175.","DOI":"10.1002\/14651858.CD009175.pub2"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fmicb.2016.00800","article-title":"Clinical features of severe or fatal mycoplasma pneumoniae pneumonia","volume":"7","author":"Izumikawa","year":"2016","unstructured":"Izumikawa K. Clinical features of severe or fatal mycoplasma pneumoniae pneumonia. Front Microbiol 2016; 7: 800.","journal-title":"Front Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/etm.2024.12559","article-title":"Exploring the pathogenetic mechanisms of mycoplasmapneumoniae (Review)","volume":"28","author":"Georgakopoulou","year":"2024","unstructured":"Georgakopoulou VE, Lempesis IG, Sklapani P, Trakas N and Spandidos DA. Exploring the pathogenetic mechanisms of mycoplasmapneumoniae (Review). Exp Ther Med 2024; 28: 271.","journal-title":"Exp Ther Med"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Hu J, Ye Y, Chen X, Xiong L, Xie W and Liu P. Insight into the pathogenic mechanism of mycoplasma pneumoniae. Curr Microbiol 2022; 80: 1-14.","DOI":"10.1007\/s00284-022-03103-0"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1088725","DOI":"10.3389\/fimmu.2022.1088725","article-title":"Serum cytokine profiling reveals different immune response patterns during general and severe mycoplasma pneumoniae pneumonia","volume":"13","author":"Zhang","year":"2022","unstructured":"Zhang Z, Dou H, Tu P, Shi D, Wei R, Wan R, Jia C, Ning L, Wang D, Li J, Dong Y, Xin D and Xu B. Serum cytokine profiling reveals different immune response patterns during general and severe mycoplasma pneumoniae pneumonia. Front Immunol 2022; 13: 1088725.","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/microorganisms8091351","article-title":"Mycoplasmas-host interaction: mechanisms of inflammation and association with cellular transformation","volume":"8","author":"Benedetti","year":"2020","unstructured":"Benedetti F, Curreli S and Zella D. Mycoplasmas-host interaction: mechanisms of inflammation and association with cellular transformation. Microorganisms 2020; 8: 1351.","journal-title":"Microorganisms"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Bordon J, Aliberti S, Fernandez-Botran R, Uriarte SM, Rane MJ, Duvvuri P, Peyrani P, Morlacchi LC, Blasi F and Ramirez JA. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 2013; 17: e76-83.","DOI":"10.1016\/j.ijid.2012.06.006"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1286364","DOI":"10.3389\/fmicb.2023.1286364","article-title":"The role and mechanism of TCM in the prevention and treatment of infectious diseases","volume":"14","author":"Zou","year":"2023","unstructured":"Zou Q, Chen Y, Qin H, Tang R, Han T, Guo Z, Zhao J and Xu D. The role and mechanism of TCM in the prevention and treatment of infectious diseases. Front Microbiol 2023; 14: 1286364.","journal-title":"Front Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"678631","DOI":"10.3389\/fphar.2021.678631","article-title":"Chinese herbal medicine for the treatment of children and adolescents with refractory mycoplasma pneumoniae pneumonia: a systematic review and a meta-analysis","volume":"12","author":"Ling","year":"2021","unstructured":"Ling X, Sun X, Kong H, Peng S, Yu Z, Wen J and Yuan B. Chinese herbal medicine for the treatment of children and adolescents with refractory mycoplasma pneumoniae pneumonia: a systematic review and a meta-analysis. Front Pharmacol 2021; 12: 678631.","journal-title":"Front Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Lee WJ, Huang EY, Tsai CM, Kuo KC, Huang YC, Hsieh KS, Niu CK and Yu HR. Role of serum mycoplasma pneumoniae IgA, IgM, and IgG in the diagnosis of mycoplasma pneumoniae-related pneumonia in school-age children and adolescents. Clin Vaccine Immunol 2017; 24: e00471-16.","DOI":"10.1128\/CVI.00471-16"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/IDR.S438202","article-title":"Efficacy and influencing factors of Sangju cough mixture in the adjuvant treatment of adult patients with mycoplasma pneumoniae Infection: a retrospective study","volume":"17","author":"Yang","year":"2024","unstructured":"Yang X, Liu Z, Liu X, Li Q, Huang H and Zhang Z. Efficacy and influencing factors of Sangju cough mixture in the adjuvant treatment of adult patients with mycoplasma pneumoniae Infection: a retrospective study. Infect Drug Resist 2024; 17: 275-282.","journal-title":"Infect Drug Resist"},{"key":"ref19","unstructured":"Yin M. Effect of Qingfei Huatan Huoxue Decoction combined with azithromycin on pulmonary function and inflammatory factors in children with mycoplasma pneumonia. Pak J Pharm Sci 2021; 34: 2317-2323."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"He H, Wang X, Xiao Y, Zheng J, Wang J and Zhang B. Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of mycoplasma pneumoniae pneumonia in children: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020; 99: e23747.","DOI":"10.1097\/MD.0000000000023747"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12882-025-04010-9","article-title":"C3 glomerulopathy associated with mycoplasma pneumoniae infection and positive IgA staining","volume":"26","author":"Duan","year":"2025","unstructured":"Duan ZY, Li JJ, Cai GY, Wang S, Tang X, Hou W, Jiang L and Song Y. C3 glomerulopathy associated with mycoplasma pneumoniae infection and positive IgA staining. BMC Nephrol 2025; 26: 85.","journal-title":"BMC Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Lee WJ, Huang EY, Tsai CM, Kuo KC, Huang YC, Hsieh KS, Niu CK and Yu HR. Role of serum mycoplasma pneumoniae IgA, IgM, and IgG in the diagnosis of mycoplasma pneumoniae-related pneumonia in school-age children and adolescents. Clin Vaccine Immunol 2017; 24: e00471-16.","DOI":"10.1128\/CVI.00471-16"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"652412","DOI":"10.3389\/fphar.2021.652412","article-title":"Traditional Chinese medicine oral liquids combined with azithromycin for mycoplasma pneumoniae pneumonia in children: a bayesian network meta-analysis","volume":"12","author":"Chen","year":"2021","unstructured":"Chen Z, Shi Q, Peng Y, Chen Y, Cao L, Pang B, Ji Z, Liu C and Zhang J. Traditional Chinese medicine oral liquids combined with azithromycin for mycoplasma pneumoniae pneumonia in children: a bayesian network meta-analysis. Front Pharmacol 2021; 12: 652412.","journal-title":"Front Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Peng Y, Chen Z, Li Y, Lu Q, Li H, Han Y, Sun D and Li X. Shuanghuanglian oral preparations combined with azithromycin for treatment of mycoplasma pneumoniae pneumonia in Asian children: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2021; 16: e0254405.","DOI":"10.1371\/journal.pone.0254405"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1431706","DOI":"10.3389\/fphar.2024.1431706","article-title":"Efficacy and safety of traditional Chinese medicine combined with azithromycin sequential therapy for mycoplasma pneumonia among children: a meta-analysis of randomized controlled trials","volume":"15","author":"Lyu","year":"2024","unstructured":"Lyu J, Fan F, Li J, Wang Q, Tian X, Xu J, Zhang S and Wang B. Efficacy and safety of traditional Chinese medicine combined with azithromycin sequential therapy for mycoplasma pneumonia among children: a meta-analysis of randomized controlled trials. Front Pharmacol 2024; 15: 1431706.","journal-title":"Front Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"765656","DOI":"10.3389\/fphar.2021.765656","article-title":"Clinical efficacy and safety of shashen maidong decoction in the treatment of pediatric mycoplasma pneumonia: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2021","unstructured":"Wang J, Ma X, Wei S, Yang T, Tong Y, Jing M, Wen J and Zhao Y. Clinical efficacy and safety of shashen maidong decoction in the treatment of pediatric mycoplasma pneumonia: a systematic review and meta-analysis. Front Pharmacol 2021; 12: 765656.","journal-title":"Front Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"102589","DOI":"10.1016\/j.eclinm.2024.102589","article-title":"Effectiveness and safety of tetracyclines and quinolones in people with mycoplasma pneumonia: a systematic review and network meta-analysis","volume":"71","author":"Cai","year":"2024","unstructured":"Cai F, Li J, Liang W, Wang L and Ruan J. Effectiveness and safety of tetracyclines and quinolones in people with mycoplasma pneumonia: a systematic review and network meta-analysis. EClinicalMedicine 2024; 71: 102589.","journal-title":"EClinicalMedicine"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"154402","DOI":"10.1016\/j.phymed.2022.154402","article-title":"Efficacy and safety of reduning injection combined with azithromycin in the treatment of mycoplasma pneumonia among children: a systematic review and meta-analysis","volume":"106","author":"Wang","year":"2022","unstructured":"Wang H, Zhao M, Liu S and Wang X. Efficacy and safety of reduning injection combined with azithromycin in the treatment of mycoplasma pneumonia among children: a systematic review and meta-analysis. Phytomedicine 2022; 106: 154402.","journal-title":"Phytomedicine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1329516","DOI":"10.3389\/fphar.2024.1329516","article-title":"Wuhu decoction combined with azithromycin for treatment of mycoplasma pneumoniae pneumonia in Asian children: a systematic review and meta analysis of randomized controlled trials","volume":"15","author":"Yang","year":"2024","unstructured":"Yang S, Liu X, Wang H, Wang H, Sun D, Han Y, Li H and Li X. Wuhu decoction combined with azithromycin for treatment of mycoplasma pneumoniae pneumonia in Asian children: a systematic review and meta analysis of randomized controlled trials. Front Pharmacol 2024; 15: 1329516.","journal-title":"Front Pharmacol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:51:47Z","timestamp":1792659107000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/12\/ajtr0168021.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/qwcj1378","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}